
Getting your Trinity Audio player ready...
|

Joe Rogan (Introduction):
Welcome, everyone, to this imaginary conversation on The Joe Rogan Experience. Today, we’re diving into an important and controversial topic: the use of repurposed drugs and alternative approaches in cancer treatment. These are therapies that are often dismissed by the mainstream medical community but have sparked incredible success stories and a growing demand for more research.
Joining us for this conversation is an incredible panel of experts and voices. First, we have Dr. Pierre Kory, a critical care specialist and advocate for repurposed drugs like ivermectin. His work has brought both praise and controversy, and he’s here to shed light on why some of these treatments are gaining traction.
Next, we have Dr. Seyfried Thomas, a leading voice on the metabolic theory of cancer, which challenges traditional genetic-based cancer research and focuses on targeting cancer cells through their energy production pathways.
Also joining us is Dr. Joe Tippens, who beat terminal cancer using fenbendazole, a drug typically used for deworming animals, and now shares his story to help others explore their options.
We’re also bringing in Dr. Mercola, an advocate for integrative medicine and a polarizing figure in alternative healthcare, who’ll speak to the challenges and potential of combining conventional and holistic approaches.
And finally, we’ve got Mel Gibson, who’s seen the impact of these treatments firsthand in his own circle and brings a unique, passionate perspective to the table.
This is going to be a deep dive into the science, the barriers, and the human stories behind these treatments. Let’s get started!

The Science of Drug Repurposing for Cancer
Joe Rogan:
"Alright, folks, we’ve got an absolutely fascinating topic today: the science behind drug repurposing for cancer. It’s a controversial field that’s gaining traction. Joining me are Dr. Pierre Kory, Dr. Seyfried Thomas, Dr. David Sinclair, and Dr. Rhonda Patrick. Let’s start with Dr. Kory. You’ve been a vocal advocate for ivermectin and other off-label drugs. What’s the scientific basis for repurposing these drugs for cancer treatment?"
Dr. Pierre Kory:
"Thanks, Joe. The idea of repurposing drugs like ivermectin is based on their known mechanisms of action. Ivermectin, for example, has been shown in lab studies to inhibit certain cellular processes in cancer cells, like reducing proliferation and promoting apoptosis—programmed cell death. While it’s primarily an antiparasitic, its ability to target microtubules and certain signaling pathways makes it a candidate for cancer research."
Joe Rogan:
"That’s wild. Dr. Thomas, you’ve done groundbreaking work on the metabolic theory of cancer. How do these drugs fit into that framework?"
Dr. Seyfried Thomas:
"Joe, the metabolic theory views cancer as a disease driven by defective mitochondrial energy metabolism. Drugs like fenbendazole, a dewormer, are thought to disrupt cancer cells by targeting glycolysis—the process cancer cells rely on for energy. By interfering with their energy production, you essentially starve the tumor. It’s a promising area that aligns with the idea of using metabolic therapies."
Joe Rogan:
"Interesting. So, it’s not just about killing cells directly but disrupting how they survive. Dr. Sinclair, you’ve spent your career studying aging and cellular resilience. What’s your take?"
Dr. David Sinclair:
"Well, Joe, aging and cancer share common pathways. Many repurposed drugs, like metformin or ivermectin, may work by targeting fundamental processes like inflammation, oxidative stress, and DNA repair. For example, methylene blue—a dye with a long history in medicine—has antioxidant properties that might help stabilize mitochondrial function in healthy cells, while disrupting cancerous ones. It’s all about shifting the balance in favor of healthy cells."
Joe Rogan:
"Fascinating. Dr. Patrick, you’ve talked a lot about optimizing health at a cellular level. How do you see these drugs playing into that?"
Dr. Rhonda Patrick:
"I think it’s crucial to understand the broader context. These drugs might work synergistically with lifestyle interventions. For example, fenbendazole or ivermectin might be more effective when paired with ketogenic diets, which lower glucose availability for tumors. We can’t just focus on the drugs in isolation. Cancer treatment, even with repurposed drugs, has to be holistic."
Joe Rogan:
"So, you’re saying the drugs are just one part of the puzzle. That makes sense. What’s holding back research into this? Is it money, politics, or something else?"
Dr. Pierre Kory:
"All of the above, Joe. Drug repurposing doesn’t make pharmaceutical companies much money because these are cheap, off-patent drugs. There’s also resistance from the medical establishment, which often prioritizes newer, more expensive treatments over inexpensive alternatives."
Dr. Seyfried Thomas:
"Agreed. It’s also about paradigm shifts. The metabolic theory of cancer challenges decades of research focused on genetic mutations. These shifts take time, but the science is solid, and it’s only a matter of educating more researchers and clinicians."
Joe Rogan:
"Sounds like a David and Goliath situation—independent researchers going up against big institutions. What’s the next step? Dr. Sinclair?"
Dr. David Sinclair:
"We need more clinical trials and interdisciplinary collaboration. These drugs have potential, but we need to prove their efficacy in rigorous studies. Crowdsourcing funding, like some cancer patients are doing for themselves, could also accelerate the process."
Joe Rogan:
"And Dr. Patrick, last word to you—what’s the takeaway for someone listening to this conversation?"
Dr. Rhonda Patrick:
"The takeaway is that there’s hope, but you should approach it with caution. Work with your doctor, explore integrative approaches, and stay informed about ongoing research. The future of cancer treatment might just be a combination of these repurposed drugs and personalized therapies."
Joe Rogan:
"This has been an eye-opener, everyone. Thanks for shedding light on this important topic. I hope this inspires more people to ask questions and demand better research. Thanks for joining me!"
Case Studies and Anecdotal Evidence
Joe Rogan:
"Alright, folks, let’s move on to something a bit more personal: case studies and anecdotal evidence. Sometimes, real-world stories are what get people to pay attention. Dr. Tippens, you’re the reason fenbendazole became so widely discussed for cancer treatment. Can you tell us your story?"
Dr. Joe Tippens:
"Sure, Joe. Back in 2017, I was diagnosed with terminal small-cell lung cancer. Doctors gave me only a few months to live. In desperation, I started taking fenbendazole—a drug meant for deworming animals—after hearing about some promising lab studies. I combined it with vitamins like E and turmeric supplements. Six months later, my scans showed no evidence of disease. That was five years ago, and I’m still cancer-free."
Joe Rogan:
"That’s incredible. But what made you try something so unconventional? Weren’t you scared?"
Dr. Joe Tippens:
"Of course I was scared. But when you’re given a terminal diagnosis, you have nothing to lose. I did my research, read studies, and made an informed decision. The response to my story has been overwhelming—thousands of people have reached out, many of whom have had similar outcomes."
Joe Rogan:
"That’s wild. Mel, you’ve also seen this in your personal life, right? Friends of yours have used these drugs?"
Mel Gibson:
"Yeah, Joe. A close friend of mine was diagnosed with late-stage cancer. He used a combination of fenbendazole, ivermectin, and methylene blue, along with his standard treatment. His doctors were shocked at how fast his tumors shrank. He’s been in remission for years now. Hearing stories like Joe’s and seeing this firsthand—it really makes you question the traditional approach."
Joe Rogan:
"Do you think your friend would have survived without these alternative treatments?"
Mel Gibson:
"It’s hard to say for sure, but the results were undeniable. These drugs might not be a magic bullet, but they’re doing something. That’s why we need more research."
Joe Rogan:
"Dr. Marik, you’ve worked in critical care for years and have seen your share of unconventional treatments. What’s your take on these stories?"
Dr. Paul Marik:
"Joe, these stories highlight what we call 'plausible anecdotal evidence.' While they don’t prove causation, they raise important questions. For example, fenbendazole targets microtubules in cancer cells, and methylene blue helps with mitochondrial function. These mechanisms make sense biologically, but we need controlled trials to separate fact from coincidence. Still, I’ve seen similar cases where patients used these drugs and experienced remarkable recoveries."
Joe Rogan:
"Why isn’t this being studied more? What’s the holdup?"
Dr. Paul Marik:
"Like we discussed earlier, it’s money and politics. Fenbendazole is dirt cheap—it’s not profitable for pharmaceutical companies to fund large trials. Plus, there’s a stigma against repurposed drugs because they don’t fit the standard profit-driven model."
Joe Rogan:
"Dr. Kory, you’ve been a strong advocate for ivermectin. Are there similar anecdotal stories from cancer patients using it?"
Dr. Pierre Kory:
"Absolutely, Joe. I’ve heard from patients and doctors around the world. One oncologist told me about a patient with advanced-stage cancer who used ivermectin alongside chemotherapy. The patient’s tumors stopped growing, and he gained years of quality life. There are also lab studies suggesting ivermectin interferes with cancer cell division and angiogenesis—how tumors build new blood vessels to grow."
Joe Rogan:
"That’s amazing. But like Dr. Marik said, how do we separate real results from false hope?"
Dr. Pierre Kory:
"We need transparency and open-mindedness. It’s not about promoting false hope; it’s about exploring possibilities responsibly. Stories like Joe’s and Mel’s friends inspire deeper investigation, and that’s how science progresses."
Joe Rogan:
"One last question for all of you. If someone listening has a terminal diagnosis and is considering these drugs, what advice would you give?"
Dr. Joe Tippens:
"Do your research. Talk to your doctor if they’re open-minded. Combine these treatments with a healthy lifestyle and don’t abandon conventional medicine."
Mel Gibson:
"Be proactive. Don’t take ‘no’ for an answer when it comes to exploring all your options. You owe it to yourself to leave no stone unturned."
Dr. Paul Marik:
"Understand the risks. These are experimental approaches, and you need to weigh the potential benefits against the unknowns."
Dr. Pierre Kory:
"Seek out a clinician who’s willing to think outside the box. With guidance, these treatments can be part of a broader strategy."
Joe Rogan:
"This has been an incredible discussion. Thanks, everyone, for sharing these stories. I hope this inspires someone to ask the tough questions and maybe even find their own path to healing."
Ethics and Safety in Experimental Treatments
Joe Rogan:
"Alright, everyone. Today we’re diving into a critical part of the conversation: ethics and safety in experimental treatments. We’ve heard some amazing stories about off-label drug use, but there’s always the question of whether this is safe and ethical. Let’s start with you, Dr. Patrick. What’s the biggest ethical concern with patients trying these treatments?"
Dr. Rhonda Patrick:
"The biggest concern is patient safety. People can be desperate when faced with a terminal diagnosis, and desperation can sometimes cloud judgment. It’s crucial to ensure that patients understand the risks, side effects, and limitations of experimental treatments. Without proper oversight, people might misuse these drugs, potentially making their condition worse."
Joe Rogan:
"That’s a solid point. Dr. Mercola, you’ve been a vocal supporter of alternative medicine. How do you balance promoting these treatments while ensuring patients aren’t taking unnecessary risks?"
Dr. Mercola:
"Great question, Joe. I always emphasize informed consent. Patients need to know exactly what they’re getting into, including potential benefits and risks. The challenge is that mainstream medicine often dismisses these options outright, leaving patients to navigate the information on their own. That’s why education and access to qualified, open-minded healthcare providers are so important."
Joe Rogan:
"Dr. Marik, you’ve worked in critical care, where decisions often have to be made quickly. What’s your perspective on using experimental treatments in high-stakes situations?"
Dr. Paul Marik:
"In critical care, we often face situations where the standard treatments aren’t working, and time is running out. In those cases, using an off-label drug isn’t just an option—it’s sometimes the only ethical choice. The key is to communicate transparently with the patient and their family, making sure they understand the rationale and risks. What’s unethical is doing nothing when there’s a plausible alternative."
Joe Rogan:
"That’s powerful. But what about the broader medical community? Why are these treatments so stigmatized?"
Dr. Paul Marik:
"Joe, it’s all about risk aversion and institutional inertia. The medical establishment is often more afraid of being wrong than missing an opportunity to help. And let’s not forget the influence of the pharmaceutical industry, which has little incentive to support off-patent drugs."
Joe Rogan:
"Dr. Thomas, your work challenges traditional cancer theories. Do you face pushback from the medical community, and how does that impact the ethics of promoting these treatments?"
Dr. Seyfried Thomas:
"Absolutely, Joe. The pushback comes from a deep-seated belief in the genetic mutation theory of cancer. When you propose something like the metabolic theory or repurposed drugs, you’re challenging decades of research and billions of dollars in funding. Ethically, I believe it’s our duty to explore all avenues, especially when the science supports it. But the roadblocks make it harder for patients to access potentially life-saving treatments."
Joe Rogan:
"Do you think these barriers are intentional, or is it just a byproduct of how the system works?"
Dr. Seyfried Thomas:
"It’s both. There’s systemic inertia, but there’s also a financial aspect. Repurposing drugs like ivermectin or fenbendazole doesn’t generate profits, so there’s little incentive for large-scale trials. That’s where ethics come in—patients shouldn’t be denied options just because they’re not profitable."
Joe Rogan:
"Dr. Patrick, what’s the role of the patient in this? Should they be more proactive in exploring these treatments?"
Dr. Rhonda Patrick:
"Absolutely, but with a caveat. Patients should be proactive but not reckless. Research the science, talk to multiple doctors, and look for clinical trials. And most importantly, don’t abandon conventional treatments without understanding the consequences. Combining the best of both worlds is often the safest path."
Joe Rogan:
"Dr. Mercola, what about the role of the media? Do you think they’re helping or hurting the conversation?"
Dr. Mercola:
"Unfortunately, the media tends to sensationalize these treatments, either as miracle cures or dangerous quackery. This polarizes the conversation and makes it harder for patients to get balanced information. What we need is honest, nuanced reporting that empowers patients rather than scaring them."
Joe Rogan:
"Alright, last question for everyone. What’s the most ethical way forward for integrating experimental treatments into mainstream medicine?"
Dr. Rhonda Patrick:
"We need more funding for research and clinical trials. That’s the only way to separate the science from the speculation."
Dr. Mercola:
"Create a system where doctors can prescribe off-label treatments without fear of backlash, as long as they’re transparent with patients."
Dr. Paul Marik:
"Develop guidelines for using repurposed drugs in palliative care and terminal cases. These patients deserve every chance."
Dr. Seyfried Thomas:
"Change the narrative. We need to educate the public and the medical community about the potential of these treatments, backed by solid science."
Joe Rogan:
"Well, folks, this has been a deep dive into one of the most important issues in medicine. Thanks to all of you for your insights. If nothing else, I hope this conversation sparks some much-needed change."
Integrative and Holistic Approaches to Cancer Treatment
Joe Rogan:
"Alright, everyone, let’s shift gears. We’ve been talking about repurposed drugs, but let’s zoom out and look at the bigger picture: integrative and holistic approaches to cancer treatment. This is where lifestyle, diet, and unconventional methods come into play. Dr. Mercola, let’s start with you. What role does holistic medicine play in cancer care?"
Dr. Mercola:
"Thanks, Joe. Holistic medicine is all about addressing the root causes of disease and creating an environment where the body can heal itself. Cancer isn’t just a localized disease—it’s often the result of systemic imbalances. Diet, stress, sleep, and toxins all play a role. Repurposed drugs like fenbendazole or ivermectin are tools, but they should be part of a larger strategy that includes things like intermittent fasting, reducing inflammation, and optimizing mitochondrial health."
Joe Rogan:
"So, you’re saying it’s not just about fighting the tumor but improving overall health to make the body inhospitable to cancer?"
Dr. Mercola:
"Exactly. You can’t just treat the tumor and ignore the terrain."
Joe Rogan:
"Dr. Patrick, you’ve talked a lot about the role of nutrition and biochemistry in health. How can that be integrated with these treatments?"
Dr. Rhonda Patrick:
"Joe, nutrition is a cornerstone of any holistic approach. For example, ketogenic diets, which drastically reduce sugar intake, can starve cancer cells that rely on glucose. Combined with drugs like fenbendazole, which disrupt cancer cell metabolism, you’re essentially attacking the disease from multiple angles. Vitamins and antioxidants also play a role, but timing is crucial—you don’t want to protect cancer cells while they’re being targeted by treatments."
Joe Rogan:
"Timing is interesting. Can you expand on that?"
Dr. Rhonda Patrick:
"Sure. For example, high-dose vitamin C can have pro-oxidant effects in cancer cells, but only when used strategically. You need to work with a knowledgeable healthcare provider who understands how these therapies interact."
Joe Rogan:
"Dr. Tippens, your story has inspired a lot of people. What holistic approaches did you combine with fenbendazole?"
Dr. Joe Tippens:
"Great question, Joe. I focused on a few key areas. First, I adopted an anti-inflammatory diet—lots of leafy greens, turmeric, and healthy fats. I also practiced mindfulness and reduced stress, which can weaken the immune system. Exercise was another big part of my recovery. All of these things complemented the fenbendazole, which was targeting the cancer cells directly."
Joe Rogan:
"Do you think you would’ve had the same results without those lifestyle changes?"
Dr. Joe Tippens:
"I honestly don’t think so. Fenbendazole was a major factor, but the lifestyle changes created a foundation for healing. It’s like building a house—you need a strong foundation, or it all falls apart."
Joe Rogan:
"Dr. Sinclair, you’ve been studying aging and longevity for years. How do those principles apply to cancer treatment?"
Dr. David Sinclair:
"Well, Joe, cancer and aging are closely linked. As we age, our cells accumulate damage, and the systems that protect us—like DNA repair and mitochondrial function—start to break down. Many of the interventions we’re discussing, like ketogenic diets and drugs like methylene blue, help restore those systems. They essentially make the body act younger and more resilient, which can slow or even reverse the progression of cancer."
Joe Rogan:
"That’s fascinating. Can these approaches also prevent cancer in the first place?"
Dr. David Sinclair:
"Absolutely. Many of the same strategies that extend lifespan—like calorie restriction, regular exercise, and avoiding toxins—also reduce the risk of cancer. Prevention is the ultimate form of treatment."
Joe Rogan:
"Let’s talk synergy. How do we combine all of these approaches—drugs, diet, lifestyle—for maximum impact? Dr. Mercola?"
Dr. Mercola:
"It starts with a personalized approach. No two patients are the same, so you need to tailor treatments to the individual. For some, that might mean combining repurposed drugs with a ketogenic diet. For others, it might mean focusing on detoxification or stress management. The key is to address the whole person, not just the disease."
Joe Rogan:
"Dr. Patrick, what’s the role of research in finding these synergies?"
Dr. Rhonda Patrick:
"Research is critical. We need more clinical trials that combine conventional and alternative therapies to see what works best. Unfortunately, most research is focused on single treatments, which doesn’t reflect how cancer patients actually live their lives."
Joe Rogan:
"Alright, last question for everyone. What’s one holistic change people can make today to improve their odds, whether they’re fighting cancer or just trying to stay healthy?"
Dr. Mercola:
"Focus on reducing inflammation. Cut out processed foods, avoid sugar, and eat whole, nutrient-dense foods."
Dr. Rhonda Patrick:
"Prioritize sleep. It’s when your body repairs itself and strengthens your immune system."
Dr. Joe Tippens:
"Find ways to reduce stress. Whether it’s meditation, yoga, or spending time with loved ones, stress can weaken your defenses."
Dr. David Sinclair:
"Start small. Even a 10% improvement in diet, exercise, or sleep can have a ripple effect on your overall health."
Joe Rogan:
"This has been an awesome discussion, guys. I love the idea of attacking cancer from every possible angle, not just with drugs but with lifestyle and mindset. Thanks for being here and sharing your insights. Hopefully, this conversation inspires some people to take control of their health."
Barriers to Mainstream Acceptance of Repurposed Drugs and Alternative Treatments
Joe Rogan:
"Alright, everyone, we’ve talked about the science and the stories, but let’s tackle the elephant in the room: why is there so much resistance to repurposed drugs and alternative treatments? Dr. Kory, you’ve been on the front lines advocating for drugs like ivermectin. What’s the main barrier you’re facing?"
Dr. Pierre Kory:
"Joe, it boils down to two things: money and reputation. Most repurposed drugs, like ivermectin, are off-patent, meaning they’re dirt cheap and don’t generate big profits. Pharmaceutical companies aren’t going to spend millions on research for something they can’t make billions from. On top of that, there’s a stigma. Doctors and researchers are afraid of damaging their reputations by going against the grain."
Joe Rogan:
"So, it’s not just science—it’s politics and economics. Dr. Seyfried, you’ve challenged the mainstream cancer theories. What kind of resistance have you seen?"
Dr. Seyfried Thomas:
"Joe, the resistance is systemic. The genetic mutation theory of cancer dominates the field because it supports the development of targeted therapies and precision medicine—both of which are highly profitable. The metabolic theory of cancer, which I advocate, doesn’t fit that model. It’s harder to monetize therapies that target something as fundamental as metabolism. And let’s not forget the institutions; they’ve built their reputations on the current paradigm, so any challenge feels like a threat."
Joe Rogan:
"Mel, as someone outside the medical world, why do you think alternative treatments struggle to gain acceptance?"
Mel Gibson:
"It’s the fear of the unknown, Joe. People trust authority, and when doctors and institutions say, ‘That’s quackery,’ most people don’t question it. But I’ve seen firsthand what happens when you step outside the box—lives are saved. The problem is, the system doesn’t reward curiosity; it punishes it. And the media plays a big role in shaping how people see these treatments."
Joe Rogan:
"Yeah, the media is a huge factor. Dr. Mercola, you’ve been in the spotlight for promoting alternative medicine. How has media backlash affected the acceptance of these treatments?"
Dr. Mercola:
"The media is part of the problem, Joe. They paint alternative medicine as either a miracle cure or complete nonsense, leaving no room for nuance. This discourages people from even considering these treatments. There’s also a coordinated effort to suppress information that threatens the status quo. Social media platforms, for example, actively censor discussions about off-label drug use, even when there’s legitimate science behind it."
Joe Rogan:
"That’s frustrating. Dr. Marik, you’ve worked in critical care and seen how the system operates. How does this resistance impact patient care?"
Dr. Paul Marik:
"It’s devastating, Joe. Patients lose out because doctors are afraid to try anything that isn’t fully endorsed by guidelines or big organizations. These guidelines are often influenced by pharmaceutical companies, which creates a conflict of interest. The result? Doctors end up treating diseases like cancer with one hand tied behind their back. It’s unethical, and it’s costing lives."
Joe Rogan:
"So, how do we fix this? How do we make it easier for these treatments to get the respect they deserve?"
Dr. Pierre Kory:
"We need independent funding for research. Right now, most clinical trials are funded by pharmaceutical companies, which creates bias. Crowdfunding and government grants could help level the playing field."
Dr. Seyfried Thomas:
"Education is key. Medical schools need to teach alternative theories like the metabolic approach to cancer, so the next generation of doctors is more open-minded."
Mel Gibson:
"People need to start asking more questions. Don’t just accept what your doctor or the media tells you. Do your own research and look for second opinions."
Dr. Mercola:
"We also need to decentralize medicine. Telemedicine, for example, can connect patients with doctors who are willing to explore alternative treatments. Technology can be a game-changer."
Dr. Paul Marik:
"And we need to protect doctors who think outside the box. Right now, they’re penalized for doing what’s best for their patients if it goes against guidelines. That has to change."
Joe Rogan:
"Alright, last question for everyone: What’s one thing the average person can do to support the acceptance of alternative treatments?"
Dr. Pierre Kory:
"Stay informed. Read the studies and understand the science so you can advocate for yourself and others."
Dr. Seyfried Thomas:
"Challenge the status quo. If something doesn’t make sense, question it—whether it’s your doctor, the media, or the system itself."
Mel Gibson:
"Share your stories. If you or someone you know has benefited from an alternative treatment, talk about it. Stories can be powerful."
Dr. Mercola:
"Be proactive about your health. Don’t wait until you’re sick to start exploring alternative options."
Dr. Paul Marik:
"Demand change. Support policies and organizations that promote unbiased research and patient-centered care."
Joe Rogan:
"This has been an eye-opening discussion. The barriers are real, but it sounds like there’s a path forward if enough people push for change. Thanks for being here, everyone. Let’s hope this conversation inspires others to take action."
Short Bios:
Dr. Pierre Kory: A critical care specialist and advocate for repurposed drugs like ivermectin, known for challenging conventional treatment protocols with evidence-backed alternatives.
Dr. Seyfried Thomas: A cancer researcher and proponent of the metabolic theory of cancer, emphasizing therapies targeting cancer cells’ energy production pathways.
Dr. David Sinclair: A Harvard researcher focused on aging and longevity, exploring how repurposed drugs and cellular health innovations intersect with cancer treatment.
Dr. Rhonda Patrick: A scientist and biochemist passionate about optimizing health through nutrition and lifestyle, integrating these approaches with medical therapies.
Dr. Joe Tippens: A cancer survivor who credits fenbendazole for his recovery, sharing his experience to inspire others to consider unconventional options.
Dr. Paul Marik: An experienced critical care physician advocating for safe, evidence-based experimental treatments for life-threatening conditions.
Dr. Mercola: A proponent of integrative and holistic medicine, emphasizing patient education and personalized approaches to health.
Mel Gibson: A renowned actor and filmmaker who has witnessed the transformative impact of alternative cancer treatments in his personal life.
Leave a Reply